NCT02103959View on ClinicalTrials.gov

Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography

PHASE2CompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Non STEMIUnstable Angina
Interventions
DRUG

CMX-2043

Slow bolus IV administration of CMX-2043

DRUG

Placebo comparator

Slow bolus IV administration of PBS

Sponsors

Lead Sponsor

Ischemix, LLC
All Listed Sponsors
lead

Ischemix, LLC

INDUSTRY